Trade Group Study: Hundreds of Rare Disease Drugs in Development

February 21, 2013 | by

According to a new report released last month by the trade group Pharmaceutical Research and Manufacturers of America (PhRMA), the biopharmaceutical pipeline is innovative and robust, with a high percentage of potential first-in-class medicines (meaning a new treatment where nothing currently exists) targeting diseases with limited treatment options. In addition to identifying medicines in development for conditions and diseases such as septic shock, ovarian cancer, sickle cell disease, and Lou Gehrig’s disease (amyotrophic lateral sclerosis), which haven’t had any new product approvals in the last ten years, the report offers positive news for the rare disease community: one third of the products currently in clinical development have a rare disease designation by the U.S. Food and Drug Administration (FDA).

PhRMA

2012: Banner Year for New Drugs

February 12, 2013 | by

Fueled by new cancer therapeutics, last year the annual new molecular and biological entity approval count from the U.S. Food and Drug Administration (FDA) saw its highest year since 1997. One-third of the novel products approved by the FDA’s Center for Drug Evaluation and Research (CDER) are used to treat cancers of the blood, breast, colon, prostate, skin and thyroid.

FDA approved

The Good News About Cancer: You Can Reduce Your Risk

November 28, 2012 | by

Rock Your Cause is a socially conscious brand with a mandate of participative philanthropy, a fancy phrase we like that simply means giving anyone and everyone the chance to be involved and support causes they are passionate about. The organization is starting a global conversation about the causes of cancer and cancer prevention.

Are You AWARxE of Counterfeit Drug Dangers Online?

August 1, 2012 | by

In difficult economic times, it’s tempting to look for ways to save money by purchasing expensive medications online. However, many online pharmacies are fake and their products can cause more harm than good. The AWARxE consumer protection program aims to educate and raise public awareness about rogue Internet drug outlets, counterfeit drug dangers, prescription drug misuse and abuse, and medication safety. Supported by the National Association of Boards of Pharmacy (NABP) Foundation, AWARxE information is developed to reach all consumers and encourages the public to rely on pharmacists for credible information on medication safety, Internet pharmacies, and counterfeit medications.

Order medicine online

Red Cross Blood Supply at Emergency Levels

July 16, 2012 | by

The Red Cross recently announced that its blood supply has reached emergency levels [1]. Donations are down more than 10% across the country, resulting in 50,000 fewer pints of blood than expected last month.

Red Cross: Emergency need for blood